Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.60
Delayed Data
As of Jul 02
 -0.0501 / -7.71%
Today’s Change
0.51
Today|||52-Week Range
3.50
-52.00%
Year-to-Date
No recent news for Endonovo Therapeutics Inc.

Today’s Trading

Previous close0.65
Today’s open0.65
Day’s range0.55 - 0.68
Volume108,782
Average volume (3 months)9,244
Market cap$68.1M
Dividend yield--
Data as of 3:56pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+99.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+5.66%
P/E ratioNM
Price/Sales1,564.98
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.2K
Annual profit (last year)-$959.5K
Net profit margin-3,966.16%

Profile

Sector
Finance
Industry
Finance/Rental/Leasing
Chairman, CEO, CFO &
Secretary
Alan Brian Collier
President &
Executive VP-Shareholder Relations
Michael Scott Mann
Corporate headquarters
Woodland Hills, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers